Trade Sana Biotechnology, Inc. - SANA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.74 |
| Open | 1.68 |
| 1-Year Change | -80.37% |
| Day's Range | 1.62 - 1.78 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 1.75 | 0.04 | 2.34% | 1.71 | 1.79 | 1.62 |
| Apr 24, 2025 | 1.74 | 0.03 | 1.75% | 1.71 | 1.77 | 1.69 |
| Apr 23, 2025 | 1.68 | -0.11 | -6.15% | 1.79 | 1.88 | 1.68 |
| Apr 22, 2025 | 1.70 | 0.09 | 5.59% | 1.61 | 1.72 | 1.59 |
| Apr 21, 2025 | 1.57 | -0.01 | -0.63% | 1.58 | 1.69 | 1.56 |
| Apr 17, 2025 | 1.62 | 0.03 | 1.89% | 1.59 | 1.63 | 1.56 |
| Apr 16, 2025 | 1.55 | -0.06 | -3.73% | 1.61 | 1.64 | 1.51 |
| Apr 15, 2025 | 1.67 | -0.12 | -6.70% | 1.79 | 1.89 | 1.63 |
| Apr 14, 2025 | 1.77 | 0.02 | 1.14% | 1.75 | 1.80 | 1.67 |
| Apr 11, 2025 | 1.74 | 0.23 | 15.23% | 1.51 | 1.76 | 1.46 |
| Apr 10, 2025 | 1.51 | 0.08 | 5.59% | 1.43 | 1.52 | 1.39 |
| Apr 9, 2025 | 1.52 | 0.20 | 15.15% | 1.32 | 1.56 | 1.30 |
| Apr 8, 2025 | 1.35 | -0.22 | -14.01% | 1.57 | 1.65 | 1.30 |
| Apr 7, 2025 | 1.51 | 0.11 | 7.86% | 1.40 | 1.62 | 1.32 |
| Apr 4, 2025 | 1.46 | 0.12 | 8.96% | 1.34 | 1.46 | 1.24 |
| Apr 3, 2025 | 1.34 | -0.12 | -8.22% | 1.46 | 1.50 | 1.31 |
| Apr 2, 2025 | 1.60 | 0.13 | 8.84% | 1.47 | 1.74 | 1.47 |
| Apr 1, 2025 | 1.47 | -0.16 | -9.82% | 1.63 | 1.64 | 1.47 |
| Mar 31, 2025 | 1.65 | 0.00 | 0.00% | 1.65 | 1.73 | 1.52 |
| Mar 28, 2025 | 1.68 | -0.11 | -6.15% | 1.79 | 1.81 | 1.65 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Sana Biotechnology, Inc. Company profile
About Sana Biotechnology Inc
Sana Biotechnology, Inc is a preclinical-stage biotechnology company. The Company is focused on creating and delivering engineered cells as medicines for patients. The Company develops in vivo and ex vivo cell engineering platforms for treatment across an array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system (CNS) disorders, cardiovascular diseases, and genetic disorders, among others. The Company’s process of repairing and controlling genes in the body, referred to as gene therapy or in vivo cell engineering, requires in vivo delivery of a therapeutic payload and modification of the genome. The Company’s fusogen technology in preclinical studies targets cell surface receptors when combined with delivery vehicles to form fusosomes and allows cell-specific delivery across multiple different cell types. It focuses this technology on delivering payloads to T cells, hepatocytes, and hematopoietic stem cells (HSCs).
Financial summary
BRIEF: For the nine months ended 30 September 2021, Sana Biotechnology Inc revenues was not reported. Net loss increased 42% to $245.2M. Higher net loss reflects Personnel increase of 36% to $55.2M (expense), General and administrative - Balancing increase of 80% to $32.6M (expense), Stock-based Compensation in R&D increase from $2.6M to $9.9M (expense).
| Industry: | Biotechnology & Medical Research (NEC) |
188 East Blaine Street, Suite 400
SEATTLE
WASHINGTON 98102
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com